Mirion Technologies (MIR) AI Stock Analysis

• Market Cap: $5.56B
• Dividend Yield: N/A
• Average Volume (3M): 5.84M
• Price to Earnings (P/E): 583.8
• Beta (1Y): 1.58
• Revenue Growth: 7.88%
• EPS Growth: N/A
• Country: US
• Employees: 2,800
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 0.11
• Shares Outstanding: 227,891,330
• 10 Day Avg. Volume: 8,519,478
• 30 Day Avg. Volume: 5,835,474
• PEG Ratio: 1.57
• Price to Book (P/B): 2.38
• Price to Sales (P/S): 4.16
• P/FCF Ratio: 71.12
• Enterprise Value/Market Cap: 1.06
• Enterprise Value/Revenue: 5.40
• Enterprise Value/Gross Profit: 11.53
• Enterprise Value/Ebitda: 28.92
• 1Y Price Target: $25.50
• Price Target Upside: 7.32% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 6

• Rating: 64 Neutral
• Price Target: $23.00 ▼(-3.20% Downside)

Mirion Technologies has a promising financial trajectory with strong revenue growth and cash flow management. However, the high P/E ratio suggests overvaluation, and challenges in certain segments pose risks. Positive technical indicators and strategic improvements from the earnings call contribute to a balanced outlook.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective sales strategies, enhancing the company's long-term financial stability.

Medical Segment Performance

Strong performance in the Medical segment suggests robust demand and competitive positioning, supporting sustained revenue and profit growth.

Improved Capital Structure

Enhanced capital structure provides financial flexibility, reducing cost of capital and enabling strategic investments for future growth.

Negative Factors

Nuclear & Safety Segment Challenges

Challenges in the Nuclear & Safety segment may hinder profitability and growth, requiring strategic adjustments to overcome these obstacles.

Lower Orders in Nuclear & Safety Segment

Decreased orders in a key segment could indicate market saturation or competitive pressures, potentially impacting future revenue streams.

Labs & Research Market Headwinds

Budget uncertainties in the Labs & Research market may limit growth opportunities, affecting long-term expansion and profitability.

Mirion Technologies Business Overview & Revenue Model

Company Description

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

How the Company Makes Money

Mirion Technologies generates revenue through multiple key streams, primarily from the sale of its radiation detection and measurement equipment, including dosimeters and monitoring systems. The company also earns income through maintenance and service contracts, providing ongoing support and calibration for its products. Additionally, Mirion benefits from strategic partnerships with key players in the nuclear and healthcare industries, allowing it to expand its market reach and enhance its product offerings. Government contracts and regulatory compliance services further contribute to its revenue, as organizations increasingly prioritize safety in radiation exposure management.

Mirion Technologies Financial Statement Overview

Summary

Mirion Technologies shows strong revenue growth and improved profitability, with a healthy gross profit margin and positive net profit margin. The balance sheet is stable with a solid equity base, though leverage should be monitored. Cash flow management is robust, with significant free cash flow generation.

Income Statement

Mirion Technologies has shown a strong improvement in revenue, with a notable revenue growth rate from 2024 to TTM (Trailing-Twelve-Months). The gross profit margin is healthy at 51.7% for TTM. Despite past losses, the net profit margin has turned positive at 1.7% in TTM, indicating improved profitability. The EBIT and EBITDA margins are relatively low, with an EBIT margin of 5.6% and EBITDA margin of 3.8%, indicating room for improvement in operational efficiency.

Balance Sheet

The company has a solid equity base with a high equity ratio of 55.3% in TTM, reflecting financial stability. However, the debt-to-equity ratio remains moderate at 0.28, which suggests a balanced approach to leverage but still poses a potential risk if not managed carefully. The return on equity is relatively low at 1.3%, indicating limited returns on shareholders' equity.

Cash Flow

Free cash flow has shown significant growth, with a substantial increase from the previous year, highlighting strong cash generation capabilities. The operating cash flow to net income ratio is robust at 8.64, indicating efficient cash utilization. The free cash flow to net income ratio is also strong at 5.97, underscoring effective cash flow management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.09B	860.80M	800.90M	717.80M	322.10M	478.20M
Gross Profit	509.90M	399.70M	356.40M	317.20M	81.10M	197.00M
EBITDA	203.30M	174.40M	149.00M	-90.80M	-19.20M	22.88M
Net Income	10.00M	-36.10M	-96.90M	-276.90M	-127.90M	-1.04M
Balance Sheet
Total Assets	2.74B	2.64B	2.72B	2.74B	3.12B	751.32M
Cash, Cash Equivalents and Short-Term Investments	262.60M	181.10M	134.10M	77.80M	88.90M	383.25K
Total Debt	420.60M	719.90M	721.00M	849.60M	860.60M	1.70B
Total Liabilities	1.22B	1.08B	1.17B	1.27B	1.33B	27.59M
Stockholders Equity	1.51B	1.51B	1.48B	1.40B	1.69B	652.05M
Cash Flow
Free Cash Flow	113.16M	50.30M	58.10M	5.20M	-16.70M	-20.85M
Operating Cash Flow	163.85M	99.10M	95.20M	39.40M	900.00K	-945.35K
Investing Cash Flow	-37.60M	-43.70M	-64.70M	-39.50M	-2.20B	-75.60M
Financing Cash Flow	39.40M	-3.30M	22.60M	-7.00M	1.54B	751.39M

Mirion Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 23.76
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MIR, the sentiment is Positive. The current price of 23.76 is above the 20-day moving average (MA) of 22.60, above the 50-day MA of 21.78, and above the 200-day MA of 18.18, indicating a bullish trend. The MACD of 0.55 indicates Positive momentum. The RSI at 56.15 is Neutral, neither overbought nor oversold. The STOCH value of 37.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MIR.

Mirion Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MWA	76 Outperform	$3.97B	26.80	16.05%	1.06%	10.19%	20.71%
FLS	72 Outperform	$7.07B	24.51	13.12%	1.55%	3.15%	14.18%
KAI	69 Neutral	$3.56B	33.70	12.96%	0.44%	1.74%	-7.64%
MIR	64 Neutral	$5.56B	583.78	0.67%	―	7.88%	―
CSW	64 Neutral	$4.08B	29.02	12.74%	0.22%	12.27%	19.05%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

Mirion Technologies Corporate Events

Mirion Technologies Secures New $450 Million Loan Tranche

On June 5, 2025, Mirion Technologies entered into Amendment No. 5 to its Credit Agreement, introducing a new $450 million tranche of term loans maturing in 2032. This amendment allows for refinancing of existing loans and offers favorable terms such as reduced interest rates contingent on achieving certain credit ratings, alongside increased flexibility for financial operations, potentially enhancing the company’s financial stability and operational capacity.

Mirion Technologies Initiates $450M Refinancing Process

On May 29, 2025, Mirion Technologies initiated a refinancing process involving a $450 million tranche of replacement term loans. These loans are expected to mature in 2032 and will be used to refinance existing term loans under a previous credit agreement. The refinancing is anticipated to close in the second quarter of 2025, although its completion is subject to certain conditions.